Search

The emergence of drug resistance among Human Immunodeficiency Virus (HIV) patients poses a significant challenge to the success of antiretroviral therapy (ART) programs globally. In Malawi, where HIV prevalence remains a major public health concern, the incorporation of Dolutegravir (DTG) into...

Background: Traditional host factors and treatment related metabolic changes are implicated in the increase of impaired glucose levels and Type 2 diabetes mellitus in HIV patients. Diabetes mellitus has specific morbidity and mortality consequences. It also contributes to the burden of other...